Therapeutic instrument and attachment thereof
US-9808372-B2 · Nov 7, 2017 · US
US9681942B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9681942-B2 |
| Application number | US-60824909-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 29, 2009 |
| Priority date | Nov 7, 2001 |
| Publication date | Jun 20, 2017 |
| Grant date | Jun 20, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method of preventing rejection of an implant in the eye, includes forming a flap in the cornea of the eye, inserting an implant under the flap, cross linking corneal tissue surrounding an implant to make the corneal tissue surrounding an implant less vulnerable to enzymatic degradation, inserting polymeric material under the corneal flap so as to overlie corneal tissue, compressing a layer of the cornea from outside using a lens having a predetermined curvature to correct refractive error of the cornea, and cross linking corneal tissue that the polymeric material overlies.
Opening claim text (preview).
What is claimed is: 1. A method of preventing rejection of an implant in the eye, comprising: forming a flap in the cornea of the eye, wherein said forming a flap includes cutting the flap with one of a micro-keratome and a femto-second laser, the flap being cut so as to have a diameter between 2 mm-12 mm and a thickness of 50 microns to 400 microns; raising the flap so as to expose stromal tissue of the cornea; applying a cross linking material in the form of Riboflavin to the stromal tissue of the cornea under the flap; inserting an implant under the flap so as to overlie the stromal tissue of the cornea; covering at least a central portion of the implant with the flap; and after said inserting the implant under the flap, cross linking corneal tissue vulnerable to enzymatic degradation surrounding the implant to decrease the vulnerability of corneal tissue surrounding the implant to enzymatic degradation, to make the corneal tissue surrounding the implant less likely to be invaded by migrating cells, and to prevent encapsulation around the implant.
characterised by electric heating · CPC title
using laser · CPC title
Cornea, e.g. artificial corneae, keratoprostheses or corneal implants for repair of defective corneal tissue · CPC title
Eye parts, e.g. lenses or corneal implants; Artificial eyes · CPC title
Correction of presbyopia · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.